Search Results - "Simmons, H. A."

Refine Results
  1. 1

    Age-Associated Pathology in Rhesus Macaques (Macaca mulatta) by Simmons, H. A.

    Published in Veterinary pathology (01-03-2016)
    “…The rhesus macaque (Macaca mulatta) is one of the most extensively used nonhuman primate models for human diseases. This article presents a literature review…”
    Get full text
    Journal Article
  2. 2

    FDA guidelines and animal models for osteoporosis by THOMPSON, D. D, SIMMONS, H. A, PIRIE, C. M, KE, H. Z

    Published in Bone (New York, N.Y.) (01-10-1995)
    “…The recent FDA Guidelines For Preclinical and Clinical Evaluation of Agents Used in the Treatment or Prevention of Postmenopausal Osteoporosis (1994) delineate…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice by Li, M., Healy, D.R., Li, Y., Simmons, H.A., Crawford, D.T., Ke, H.Z., Pan, L.C., Brown, T.A., Thompson, D.D.

    Published in Bone (New York, N.Y.) (01-07-2005)
    “…The EP4 receptor, one of the subtypes of the prostaglandin E 2 (PGE 2) receptor, plays a critical role in the anabolic effects of PGE 2 on bone. However, its…”
    Get full text
    Journal Article
  4. 4

    Evaluation of risks of viral transmission to recipients of bovine embryos arising from fertilisation with virus-infected semen by Wrathall, A.E., Simmons, H.A., Van Soom, A.

    Published in Theriogenology (20-01-2006)
    “…This scientific review was prompted by recent legislation to curtail the use of semen from potentially virus-infected bulls to produce embryos for import into…”
    Get full text
    Journal Article
  5. 5

    Molecular Orientation and Two-Component Nature of the Crystalline Fraction of Spider Dragline Silk by Simmons, Alexandra H., Michal, Carl A., Jelinski, Lynn W.

    “…The molecular origin of the exceptional mechanical properties of spider silk is unclear. This paper presents solid-state $^2$H nuclear magnetic resonance data…”
    Get full text
    Journal Article
  6. 6

    Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice by Li, M., Pan, L.C., Simmons, H.A., Li, Y., Healy, D.R., Robinson, B.S., Ke, H.Z., Brown, T.A.

    Published in Bone (New York, N.Y.) (01-10-2006)
    “…It has been hypothesized that activation of peroxisome-proliferator-activated receptor-γ (PPARγ) by thiazolidinedione drugs can increase adipogenesis at the…”
    Get full text
    Journal Article
  7. 7

    Clinical and Pathologic Features of West Nile Virus Infection in Native North American Owls (Family Strigidae) by Fitzgerald, S. D, Patterson, J. S, Kiupel, M, Simmons, H. A, Grimes, S. D, Sarver, C. F, Fulton, R. M, Steficek, B. A, Cooley, T. M, Massey, J. P, Sikarskie, J. G

    Published in Avian diseases (01-07-2003)
    “…Since the initial report of West Nile virus in the northeastern United States in 1999, the virus has spread rapidly westward and southward across the country…”
    Get full text
    Journal Article
  8. 8

    Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model by Ke, H.Z., Chen, H.K., Simmons, H.A., Qi, H., Crawford, D.T., Pirie, C.M., Chidsey-Frink, K.L., Ma, Y.F., Jee, W.S.S., Thompson, D.D.

    Published in Bone (New York, N.Y.) (1997)
    “…The purpose of this study was to compare the effects of droloxifene (DRO), tamoxifen (TAM), and 17α-ethynyl estradiol (EE) on bone mineral density, bone…”
    Get full text
    Journal Article
  9. 9

    West Nile Virus Infection in Eastern Fox Squirrels (Sciurus niger) by Kiupel, M., Simmons, H. A., Fitzgerald, S. D., Wise, A., Sikarskie, J. G., Cooley, T. M., Hollamby, S. R., Maes, R.

    Published in Veterinary pathology (01-11-2003)
    “…Since the initial outbreak of West Nile virus (WNV) in the northeastern United States in 1999, the virus has rapidly spread westward and southward across the…”
    Get full text
    Journal Article
  10. 10

    Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia by Ke, H.Z, Shen, V.W, Qi, H, Crawford, D.T, Wu, D.D, Liang, X.G, Chidsey-Frink, K.L, Pirie, C.M, Simmons, H.A, Thompson, D.D

    Published in Bone (New York, N.Y.) (01-09-1998)
    “…It is well documented that prostaglandin E2 (PGE2) has the ability to stimulate bone formation, improve bone structure, and increase bone mass in intact or…”
    Get full text
    Journal Article
  11. 11

    Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats by KE, H. Z, CHEN, H. K, QI, H, PIRIE, C. M, SIMMONS, H. A, MA, Y. F, JEE, W. S. S, THOMPSON, D. D

    Published in Bone (New York, N.Y.) (01-11-1995)
    “…The purpose of this study was to determine the efficacy of droloxifene (DRO), an estrogen antagonist/agonist, in preventing ovariectomy (OVX)-induced lumbar…”
    Get full text
    Journal Article
  12. 12

    Parathyroid hormone (1-34) increased total body bone mass in aged female rats by Simmons, H A, Pirie, C M, Thompson, D D, Ke, H Z

    “…Daily subcutaneous administration of bovine parathyroid hormone (PTH)(1-34) stimulates bone formation and increases bone mass in rat tibiae, femora and lumbar…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Risks of transmitting ruminant spongiform encephalopathies (prion diseases) by semen and embryo transfer techniques by Wrathall, A.E., Holyoak, G.R., Parsonson, I.M., Simmons, H.A.

    Published in Theriogenology (15-09-2008)
    “…Early experiments suggested that scrapie transmission via sheep embryos was a possibility, and gave rise to much controversy. However, when account is taken of…”
    Get full text
    Journal Article
  15. 15

    Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones by Simmons, Hollis A., Raisz, Lawrence G.

    Published in Journal of bone and mineral research (01-12-1991)
    “…We tested acid and basic fibroblast growth factor (aFGF and bFGF), members of the heparin binding FGF family, for their ability to stimulate bone resorption as…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats by KE, H. Z, CRAWFORD, D. T, QI, H, PIRIE, C. M, SIMMONS, H. A, CHIDSEY-FRINK, K. L, CHEN, H. K, JEE, W. S. S, THOMPSON, D. D

    Published in Bone (New York, N.Y.) (1999)
    “…Droloxifene (DRO) is a selective estrogen receptor modulator that prevents bone loss by inhibition of bone turnover associated with estrogen deficiency in both…”
    Get full text
    Journal Article
  18. 18

    The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons by Thompson, D.D., Seedor, J.G., Quartuccio, H., Solomon, H., Fioravanti, C., Davidson, J., Klein, H., Jackson, R., Clair, J., Frankenfield, D., Brown, E., Simmons, H.A., Rodan, G.A.

    Published in Journal of bone and mineral research (01-08-1992)
    “…We examined the effect of the amino bisphosphonate alendronate, administered IV every 2 weeks at 0.05 and 0.25 mg/kg for 1 year, on bone loss and parameters…”
    Get full text
    Journal Article
  19. 19

    Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats by CHEN, H. K, KE, H. Z, LIN, C. H, MA, Y. F, QI, H, CRAWFORD, D. T, PIRIE, C. M, SIMMONS, H. A, JEE, W. S. S, THOMPSON, D. D

    Published in Bone (New York, N.Y.) (01-10-1995)
    “…Droloxifene (DRO), an estrogen antagonist/agonist, has been shown to possess estrogen-like effects in inhibiting bone turnover leading to cancellous bone loss…”
    Get full text
    Conference Proceeding Journal Article
  20. 20

    Droloxifene prevents ovariectomy‐induced bone loss in tibiae and femora of aged female rats: A dual‐energy X‐ray absorptiometric and histomorphometric study by Chen, Hong Ka, Ke, Hua Zhu, Jee, Webster S. S., Ma, Yan Fei, Pirie, Christine M., Simmons, Hollis A., Thompson, David D.

    Published in Journal of bone and mineral research (01-08-1995)
    “…Our previous studies indicated that droloxifene (DRO), a tissue‐specific estrogen antagonist/agonist, prevented bone loss without causing uterine hypertrophy…”
    Get full text
    Journal Article